When: Price reaches $189-$191 (upper Bollinger Band)

Then: Reduce position 25-33% into strength

When: Close below $165.40 (50 SMA)

Then: Exit position—structural trend invalidation

HOLD

• Three consecutive plaintiff verdicts signal defense theory isn't resonating with juries; 2,000+ more plaintiffs queued means each bellwether compounds credibility issues
• Contingent liability ceiling of $40 billion if all plaintiffs win (at $20M average verdict) represents binary risk, not tail risk
• Stockholder equity of $2.95B against $34.9B in assets with negative tangible book value leaves zero margin to absorb adverse litigation outcomes
• RSI at 69.7 is one strong up day from formal overbought reading above 70; prior 77.31 reading on July 28 was followed by pullback to 64.6 by July 30
• MACD at 5.74 has expanded 8-fold in three weeks; momentum extension makes mean reversion mathematically certain, not just possible
• Expected value entering at current levels is negative: ~$19 downside to 50 SMA at $165.40 versus ~$6 upside to upper band
• Forward P/E of 18.8x anchored on forward EPS of $9.78 assumes 74% earnings recovery from TTM $5.62; recovery thesis depends on litigation containment, restructuring, and buyback continuation
• Current ratio of 1.24 is tight, not comfortable; $10.9B long-term debt against $2.95B equity limits ability to absorb $200M adverse verdict without credit impact
• 3-year return of 137.6% was driven by multiple expansion during post-2022 disinflation; this structural tailwind is weakening
• Proposed stop at $175.80 (10 EMA) sits above structural support at $165.40 (50 SMA); routine volatility tag would only begin to expose actual downside

→ vs aggressive: 60.61 basis point framing of Watson Grinding verdict misrepresents risk; pattern and trajectory matter more than single verdict size

→ vs aggressive: Breakout thesis math shows negative expected value; 1% position sizing doesn't make a bad bet sound—it just limits loss amount

→ vs aggressive: Stop at $175.80 (10 EMA) is above structural support at $165.40 (50 SMA), creating ~$19 true downside exposure versus advertised ~$8.50

→ vs aggressive: Forward P/E of 18.8x depends on 74% earnings recovery assumption; DCF upside isn't more reliable than trailing multiples—it's dependent on assumptions

→ vs aggressive: Current ratio of 1.24 is tight, not comfortable; negative tangible book is 'technically accurate but functionally meaningless'

→ vs aggressive: Neutral macro is absence of catalyst, not supportive environment; post-2022 multiple expansion tailwind is structurally weakening

→ vs aggressive: Trade is speculation with stop loss attached, not a structured trade; positive expected value and thesis independence are required for structured classification

HOLD with modified framework: reduced-size add (0.5% equity) on breakout above $184.38 using 50 SMA ($165.40) as stop, defensive add zone narrowed to $175-$178, no position increases within 2 weeks of MDL bellwether dates or earnings

• Aggressive analyst's bullish stack valid (10 EMA, 50 SMA, 200 SMA rising in order, ATR compression), but treating trend as invincible is momentum trader's mistake
• RSI at 69.7 is yellow caution light, not green light for aggressive entry
• MACD expansion from 0.71 to 5.74 will mean-revert; aggressive response is faith, not analysis
• Breakout trade structure flawed: 1% equity position with stop at $175.80 (below 10 EMA) gets tagged and misses the move to $190; stop should be at 50 SMA ($165.40)
• Breakout trade risk-reward is actually 1.9:1 against, not 2.1:1 favorable as aggressive analyst claims
• Conservative analyst's expected value calculation directionally correct but quantitatively overstated; 50 SMA moves higher during breakout
• Defensive add at $165-$170 requires 10% pullback which may not come; waiting for it risks chasing at higher prices
• Litigation real overhang but not binary extinction event; 3 plaintiff verdicts concerning but bellwether reversal possible
• PFAS settlements historically resolve at 20-40% of theoretical max, not worst-case $40B scenario
• Forward P/E of 18.8x against forward EPS of $9.78 reasonable only if earnings recovery materializes
• Position sizing of 0.5-1.5% of equity is correct framework for uncertainty
• Q3 earnings likely late October; MDL bellwether dates are known catalysts to incorporate into plan

→ vs aggressive: Breakout trade with 1% position and stop at $175.80 is not structured—it gets stopped out and misses the actual move to $190; stop must be below 50 SMA at $165.40, changing risk-reward to 1.9:1 against, not 2.1:1 for

→ vs aggressive: MACD expansion from 0.71 to 5.74 will mean-revert; dismissing this concern is faith, not analysis

→ vs aggressive: RSI at 69.7 is yellow caution light, not green light being treated as invitation to overcommit

→ vs conservative: Expected value calculation at -$184.38 directionally correct but quantitatively overstated; 50 SMA at $165.40 doesn't stay static during breakout

→ vs conservative: Defensive add at $165-$170 is not a free option—it requires 10% pullback that may not materialize while trend runs to $195

→ vs conservative: Litigation treated as maximum damages scenario; historical MDL settlements resolve at 20-40% of theoretical maximum, not worst-case $40B stacking